ask="7.050"
ask_size="400"
average_daily_volume="487315"
bid="6.800"
bid_size="100"
book_value="3.063"
change="+0.115"
change_from_200_day_moving_average="-1.220"
change_from_50_day_moving_average="-0.262"
change_from_52_week_high="-3.835"
change_From_52_week_low="3.285"
change_in_percent="+1.696%"
close="6.895"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.664"
ebitda="-16.43M"
eps_estimate_current_year="-0.710"
eps_estimate_next_quarter="-0.340"
eps_estimate_next_year="-1.200"
ex_dividend_date="N/A"
float_shares="31566000"
high="7.200"
high_52_weeks="10.730"
last_trade_date="3/2/2017"
last_trade_price="6.895"
last_trade_size="4212"
last_trade_time="4:00pm"
low="6.670"
low_52_weeks="3.610"
market_capitalization="255.42M"
moving_average_200_day="8.115"
moving_average_50_day="7.157"
name="Aratana Therapeutics
Inc."
notes="N/A"
one_year_target_price="10.800"
open="6.760"
pe_ratio="N/A"
peg_ratio="-0.620"
percent_change_from_200_day_moving_average="-15.039%"
percent_change_from_50_day_moving_average="-3.658%"
percent_change_from_52_week_high="-35.741%"
percent_change_from_52_week_low="+90.997%"
previous_close="6.780"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.214"
price_per_sales="6.554"
revenue="38.32M"
shares_outstanding="37044000"
short_ratio="8.780"
stock_exchange="NGM"
symbol="PETX"
volume="568798"
weeks_range_52="3.610 - 10.730"
